New data from the ADVANCE trial suggest elevations in viral load for people on dolutegravir often signal treatment disruption, and viral re-suppression is possible without changing antiretrovirals.
Final data from the REPRIEVE trial show pitavastatin therapy is associated with a significantly lower risk of cardiovascular events than placebo as evidence grows for statins in primary prevention.
Harry and Meghan address tumultuous relationship with the media in Netflix doc pressandjournal.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressandjournal.co.uk Daily Mail and Mail on Sunday newspapers.